newsfilter
← Latest News
GlobeNewswire·

Axsome Therapeutics to Participate in Upcoming Investor Conferences

  • Axsome Therapeutics (NASDAQ: AXSM) will participate in four investor conferences in November 2026.
  • The company will hold a Fireside Chat at the Guggenheim 3rd Annual Healthcare Innovation Conference on Monday, November 9, 2026, in Boston.
  • Investor meetings at the 8th Annual Wolfe Research Healthcare Conference are scheduled for Tuesday, November 10, 2026, in New York.
  • Investor meetings at the 2026 Truist BioPharma Symposium will take place on Thursday, November 12, 2026, in New York.
  • A Fireside Chat at the UBS Global Biopharma Conference 2026 is set for Monday, November 16, 2026, in London.
  • Live webcasts for the Guggenheim 2026 2026 UBS presentations will be available on the company website, with replays accessible for approximately 30 days.
  • Axsome Therapeutics has an industry-leading neuroscience portfolio including FDA-approved treatments for major depressive disorder, agitation associated with dementia due to Alzheimer's disease, excessive daytime sleepiness associated with narcolepsy 2026 obstructive sleep apnea, 2026 migraine.
  • Forward-looking statements in the release address risks regarding commercial success, payer coverage, clinical trial timing 2026 costs, regulatory approvals, intellectual property, 2026 capital requirements, 2026 geopolitical factors.